خانم حسینی

خانم حسینی

Psoriasis

Tuesday, 05 September 2017 04:25

Death risk almost doubles with severe psoriasis, study suggests

Adults whose psoriasis covers at least 10 percent of their body surface area are at almost twice the risk of early death than those without the disease, new research suggests.The study is believed to be the first to objectively measure how the severity of psoriasis might influence a patient's mortality.Lead author Dr. Megan H. Noe, of the Perelman School of Medicine at the University of Pennsylvania, and colleagues recently reported their results in the Journal of Investigative Dermatology.

Psoriasis is a disease triggered by abnormal immune system activity that leads to an excess production of skin cells. As a result, skin cells build up, causing patches of thick, dry, scaly skin.The elbows, knees, scalp, lower back, face, palms, and the soles of feet are most commonly affected by psoriasis, but it can also affect other parts of the body, including the fingernails and toenails.

Eczema

Thursday, 11 June 1401 00:00

Eczema: Causes, symptoms, and treatments

Eczema is a condition where patches of skin become inflamed, itchy, red, cracked, and rough. Blisters may sometimes occur. It affects a large section of the American population to a lesser or greater degree.

The word eczema is also used specifically to refer to atopic dermatitis, the most common type of eczema. In this article, we will explain what eczema is and discuss the causes, symptoms, and treatments.

BIOGENA

Monday, 02 October 2017 05:41

Welcome to diversity

Minerals, trace elements, vitamins, enzymes and amino acids: Biogena offers a wide range of meticulously manufactured nutrient preparations "made in Austria".

 

Event 2017

We at Biogena want to make our valuable health knowledge available to a maximum of people through free lectures. Our lectures take place in all big cities in Austria, Germany, Italy and Switzerland. Benefit from valuable expert knowledge!

PROCESS FOR PRF

Thursday, 22 March 1398 00:00

PRF 

 PRF

The concept of PRF (Platelet Rich Fibrin) is based on the centrifugation of whole blood without anticoagulants. (J. Choukroun et al. 2001). At the end of the spin, a fibrin clot containing the majority of the platelets and white blood cells is obtained.

This fibrin clot called Platelet Riche Fibrin or PRF  will release gradually and growth factors or cytokines in the site (VEGF, PDGF, TGF Beta, Thrombospondin) .The expected objective of these growth factors is to accelerate the soft tissue and bone healing.Numerous international publications are available and demonstrate the effectiveness of PRF in many indications: oral surgery (implants, bone grafting, periodontal surgery, extractions, etc...), Orthopedic, cosmetic and dermatological surgery. Today, the PRF is recognized around the world, from Nice to New York from Los Angeles to Shanghai, from Rangoon to Moscow, from Sao Paulo to Cape Town, Santiago to Zagreb...

Its effectiveness is definitely proven.

SUNSTAR GUIDOR

Saturday, 26 August 2017 07:13

 

GUIDOR® easy-graft

100 % alloplastic bone graft system
Soft from the syringe
Mouldable in the Defect
In situ hardening

AMNIGRAFT

Monday, 02 October 2017 05:42

AMNIGRAFT Wound Allograft is indicated for use as a wound covering for dermal ulcers and defects. Amnigraft reduces scar tissue
formation, modulates inflammation in the surgical site, enhances healing, and acts as a barrier.
Human amniotic membrane comprises the innermost layer of the placenta and lines the amniotic cavity. Other forms of the same type of placental tissue have been used for 100 years; this type of tissue is becoming a standard wound treatment for chronic wounds. Amnigraft is rich with the basic components necessary for tissue repair and wound healing. They contain collagen substrates, growth factors, amino acids, carbohydrates, and cytokines, which are known to facilitate migration and proliferation cells to the site of injury and help construct a natural scaffold on which new tissue growth can occur. Amnigraft is processed through the process that combines cleaning, dehydration and sterilization, and it may be stored at ambient conditions for up to 3 years. The proprietary protects the delicate scaffold during processing, leaving an intact collagen matrix. The result is a durable graft with natural barrier properties to optimize surgical performance and ease of use.

plagrafDes

SORIEF

Thursday, 20 March 0780 00:00

Introduction

Sorief  is a biopolymeric composite wound dressing Film (NBF) which is fabricated by combining the natural/synthetic polymers. This bio composite film is as non- drug based.
In a subset of wounds that had not been responsive to prior treatment (injection and etc.), a decrease in wound size of 95% was observed after three weeks of treatment by NBF.

Design, function

The goal of this project is design a bio polymeric composite wound dresser in which no drug is used. In this approach, combination of natural polymer like chitosan, Gelatin, Collagen, and artificial polymer like polyvinyl alcohol is mixed with determinate percentages without using drug and using an automatic film applicator of thin film is covered in one face and then it is dried in room temperature and sterilized afterwards.
This dressing will be especially beneficial to patients who suffer from infected wounds (such as diabetic wound, cutaneous leishmaniasis wound and ….) by providing relief not only in the realm of pain management and of olfaction but also in improvements in cost and in overall treatment time.  
Wound dressings based on NBF absorb aqueous fluids such as wound secretions quickly, and protect wounds from dirt and microbes, and promote rapid healing.
•    NBF is a transparent adhesive wound dressing consisting of a wound contact layer of natural and synthetic polymer with or without backing layer which is impermeable to liquids and bacteria. On contact with a wound the films takes up the wound exudates whereby a gel is formed that ensures a moist wound environment.  The gel layer prevents film from sticking to the wound.

info@nojandaroo.com

NOJANDAROO.COM

Nojan Daroo Sandos

Nojan Daroo Sandos Co., Produces High-Technology Products in the Special Treatment of Acute and Chronic Wounds and Also Exclusive Representative of Biogena Austria, France Process for PRF, Swiss SunStar Companies in Iran.

: No.52, 10. Banafsheh St. ,Otrish Sq, shahrak golestan, Tehran-Iran
: (+9821)47380-9
Contact us
  Mail is not sent.   Your email has been sent.